đ Canary Capitalâs INJ ETF Nears SEC Approval â Injective (INJ) Primed for Liftoff
Wall Street's sleeping giant just yawned. The SEC is reportedly warming to Canary Capital's proposed Injective (INJ) ETFâa move that could send shockwaves through both TradFi and DeFi.
The Backroom Game
Insiders whisper the approval process has shifted from 'if' to 'when.' Injective's institutional-grade infrastructureâbuilt for compliance from day oneâis finally paying off. Meanwhile, crypto OGs smirk at the irony: the same regulators who dragged their feet now scramble to tame the beast they ignored.
Market Calculus
An INJ ETF would unlock billions in dormant capital. Pension funds chasing yield? Check. Hedge funds hedging against dollar decay? Double-check. The real question isn't about adoptionâit's about how fast the suits can slap 'risk-managed' labels on what's essentially a rocket ship.
The Punchline
Watch the SEC approve this with fanfare, then take credit for 'bringing order to chaos'ânever mind they're 10 years late to the party. Injective? It'll keep building while bureaucrats play catch-up.
In a major development for digital finance, Canary Capital has filed a unique staked INJ ETF with the Securities and Exchange Commission (SEC). This is the first-ever regulated investment product in the U.S. t... Read More
